Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You currently use or have previously used drugs by injection or by snorting through the nose
- You are currently on a prescribed medication programme to help manage opioid (e.g. heroin) dependence, such as methadone or buprenorphine
Who may not be able to join:
- You have a known active viral infection (such as HIV or hepatitis) that is currently active in your body (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ghassan RIACHI, MD, University Hospital, Rouen
Phone: +3323288
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of person with an active hepatitis C infection; Number of person with an active hepatitis B infection; Number of person with an active AIDS infection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.